Short Interest in Omron Corp. (OTCMKTS:OMRNY) Rises By 116.6%

Omron Corp. (OTCMKTS:OMRNY) saw a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 27,640 shares, a growth of 116.6% from the February 12th total of 12,759 shares. Based on an average daily volume of 63,509 shares, the short-interest ratio is presently 0.4 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 63,509 shares, the short-interest ratio is presently 0.4 days.

Omron Stock Down 3.5%

Shares of OMRNY opened at $29.69 on Thursday. The company’s 50-day simple moving average is $28.65 and its 200-day simple moving average is $27.34. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.11. Omron has a 1 year low of $23.23 and a 1 year high of $35.90. The stock has a market capitalization of $6.12 billion, a PE ratio of 37.58, a P/E/G ratio of 0.48 and a beta of 0.92.

Omron (OTCMKTS:OMRNY) last announced its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.19). The business had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Analysts forecast that Omron will post 0.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC boosted its stake in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. Institutional investors own 1.09% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of “Hold”.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.